scholarly journals Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung)

2019 ◽  
Vol 30 ◽  
pp. v646-v647 ◽  
Author(s):  
D. Heudobler ◽  
C. Schulz ◽  
J.R. Fischer ◽  
P. Staib ◽  
T. Wehler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Randomized Phase Ii ◽  
Low Dose Chemotherapy

scholarly journals Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

2004 ◽  
Vol 10 (15) ◽  
pp. 5022-5026 ◽  
Author(s):  
Martin J. Edelman ◽  
Joseph I. Clark ◽  
Kari Chansky ◽  
Kathy Albain ◽  
Nirmala Bhoopalam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Sequential Chemotherapy ◽  
Randomized Phase Ii

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non???Small-Cell Lung Cancer

2006 ◽  
Vol 1 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Gregory A. Masters ◽  
Athanassios E. Argiris ◽  
Elizabeth A. Hahn ◽  
J Thaddeus Beck ◽  
P Gregory Rausch ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document